Filipe, da S., , Hughes, J. ., Aranday-Cortes, E. ., Irving, W. ., Foster, G. ., … Thomson, E. . (2018). Reply to: No effect of resistance-associated substitutions in patients with rare HCV subtypes following treatment with sofosbuvir-containing regimens. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2017.11.044 (Original work published 2018)